Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.

Market Analysis and Insights: Global Parkinson’s Disease Treatment Market

The global Parkinson’s Disease Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Parkinson’s Disease Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Parkinson’s Disease Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Parkinson’s Disease Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Parkinson’s Disease Treatment include Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, Impax Pharmaceuticals, UCB, AbbVie and MSD, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Parkinson’s Disease Treatment is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Parkinson’s Disease Treatment industry development. In 2023, global % revenue of Parkinson’s Disease Treatment went into Hospital Pharmacy filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Parkinson’s Disease Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Parkinson’s Disease Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Parkinson’s Disease Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parkinson’s Disease Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Parkinson’s Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Parkinson’s Disease Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Parkinson’s Disease Treatment Market Report

Report Metric	Details
Report Name	Parkinson’s Disease Treatment Market
Segment by Type	Oral Transdermal Subcutaneous Intestinal Infusion
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, Impax Pharmaceuticals, UCB, AbbVie, MSD, Orion Pharmaceuticals, Intec Pharma, NeuroDerm, Adamas Therapeutics, Acadia, Sunovion, GSK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Parkinson’s Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson’s Disease Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parkinson’s Disease Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Parkinson’s Disease Treatment Market report?

Ans: The main players in the Parkinson’s Disease Treatment Market are Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, Impax Pharmaceuticals, UCB, AbbVie, MSD, Orion Pharmaceuticals, Intec Pharma, NeuroDerm, Adamas Therapeutics, Acadia, Sunovion, GSK

What are the Application segmentation covered in the Parkinson’s Disease Treatment Market report?

Ans: The Applications covered in the Parkinson’s Disease Treatment Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Parkinson’s Disease Treatment Market report?

Ans: The Types covered in the Parkinson’s Disease Treatment Market report are Oral, Transdermal, Subcutaneous, Intestinal Infusion

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Transdermal

1.2.4 Subcutaneous

1.2.5 Intestinal Infusion

1.3 Market by Application

1.3.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Parkinson’s Disease Treatment Market Perspective (2019-2030)

2.2 Global Parkinson’s Disease Treatment Growth Trends by Region

2.2.1 Parkinson’s Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Parkinson’s Disease Treatment Historic Market Size by Region (2019-2024)

2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Region (2025-2030)

2.3 Parkinson’s Disease Treatment Market Dynamics

2.3.1 Parkinson’s Disease Treatment Industry Trends

2.3.2 Parkinson’s Disease Treatment Market Drivers

2.3.3 Parkinson’s Disease Treatment Market Challenges

2.3.4 Parkinson’s Disease Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Parkinson’s Disease Treatment by Players

3.1.1 Global Parkinson’s Disease Treatment Revenue by Players (2019-2024)

3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Parkinson’s Disease Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Parkinson’s Disease Treatment Market Concentration Ratio

3.4.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2023

3.5 Global Key Players of Parkinson’s Disease Treatment Head office and Area Served

3.6 Global Key Players of Parkinson’s Disease Treatment, Product and Application

3.7 Global Key Players of Parkinson’s Disease Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson’s Disease Treatment Breakdown Data by Type

4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2019-2024)

4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2025-2030)

5 Parkinson’s Disease Treatment Breakdown Data by Application

5.1 Global Parkinson’s Disease Treatment Historic Market Size by Application (2019-2024)

5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Parkinson’s Disease Treatment Market Size (2019-2030)

6.2 North America Parkinson’s Disease Treatment Market Size by Type

6.2.1 North America Parkinson’s Disease Treatment Market Size by Type (2019-2024)

6.2.2 North America Parkinson’s Disease Treatment Market Size by Type (2025-2030)

6.2.3 North America Parkinson’s Disease Treatment Market Share by Type (2019-2030)

6.3 North America Parkinson’s Disease Treatment Market Size by Application

6.3.1 North America Parkinson’s Disease Treatment Market Size by Application (2019-2024)

6.3.2 North America Parkinson’s Disease Treatment Market Size by Application (2025-2030)

6.3.3 North America Parkinson’s Disease Treatment Market Share by Application (2019-2030)

6.4 North America Parkinson’s Disease Treatment Market Size by Country

6.4.1 North America Parkinson’s Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Parkinson’s Disease Treatment Market Size by Country (2019-2024)

6.4.3 North America Parkinson’s Disease Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Parkinson’s Disease Treatment Market Size (2019-2030)

7.2 Europe Parkinson’s Disease Treatment Market Size by Type

7.2.1 Europe Parkinson’s Disease Treatment Market Size by Type (2019-2024)

7.2.2 Europe Parkinson’s Disease Treatment Market Size by Type (2025-2030)

7.2.3 Europe Parkinson’s Disease Treatment Market Share by Type (2019-2030)

7.3 Europe Parkinson’s Disease Treatment Market Size by Application

7.3.1 Europe Parkinson’s Disease Treatment Market Size by Application (2019-2024)

7.3.2 Europe Parkinson’s Disease Treatment Market Size by Application (2025-2030)

7.3.3 Europe Parkinson’s Disease Treatment Market Share by Application (2019-2030)

7.4 Europe Parkinson’s Disease Treatment Market Size by Country

7.4.1 Europe Parkinson’s Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Parkinson’s Disease Treatment Market Size by Country (2019-2024)

7.4.3 Europe Parkinson’s Disease Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Parkinson’s Disease Treatment Market Size (2019-2030)

8.2 China Parkinson’s Disease Treatment Market Size by Type

8.2.1 China Parkinson’s Disease Treatment Market Size by Type (2019-2024)

8.2.2 China Parkinson’s Disease Treatment Market Size by Type (2025-2030)

8.2.3 China Parkinson’s Disease Treatment Market Share by Type (2019-2030)

8.3 China Parkinson’s Disease Treatment Market Size by Application

8.3.1 China Parkinson’s Disease Treatment Market Size by Application (2019-2024)

8.3.2 China Parkinson’s Disease Treatment Market Size by Application (2025-2030)

8.3.3 China Parkinson’s Disease Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Parkinson’s Disease Treatment Market Size (2019-2030)

9.2 Asia Parkinson’s Disease Treatment Market Size by Type

9.2.1 Asia Parkinson’s Disease Treatment Market Size by Type (2019-2024)

9.2.2 Asia Parkinson’s Disease Treatment Market Size by Type (2025-2030)

9.2.3 Asia Parkinson’s Disease Treatment Market Share by Type (2019-2030)

9.3 Asia Parkinson’s Disease Treatment Market Size by Application

9.3.1 Asia Parkinson’s Disease Treatment Market Size by Application (2019-2024)

9.3.2 Asia Parkinson’s Disease Treatment Market Size by Application (2025-2030)

9.3.3 Asia Parkinson’s Disease Treatment Market Share by Application (2019-2030)

9.4 Asia Parkinson’s Disease Treatment Market Size by Region

9.4.1 Asia Parkinson’s Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Parkinson’s Disease Treatment Market Size by Region (2019-2024)

9.4.3 Asia Parkinson’s Disease Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Details

11.1.2 Teva Business Overview

11.1.3 Teva Parkinson’s Disease Treatment Introduction

11.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.1.5 Teva Recent Developments

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Parkinson’s Disease Treatment Introduction

11.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.2.5 Roche Recent Developments

11.3 Prothena

11.3.1 Prothena Company Details

11.3.2 Prothena Business Overview

11.3.3 Prothena Parkinson’s Disease Treatment Introduction

11.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.3.5 Prothena Recent Developments

11.4 Acorda Therapeutics

11.4.1 Acorda Therapeutics Company Details

11.4.2 Acorda Therapeutics Business Overview

11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Introduction

11.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.4.5 Acorda Therapeutics Recent Developments

11.5 Voyager Therapeutics

11.5.1 Voyager Therapeutics Company Details

11.5.2 Voyager Therapeutics Business Overview

11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Introduction

11.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.5.5 Voyager Therapeutics Recent Developments

11.6 Impax Pharmaceuticals

11.6.1 Impax Pharmaceuticals Company Details

11.6.2 Impax Pharmaceuticals Business Overview

11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Introduction

11.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.6.5 Impax Pharmaceuticals Recent Developments

11.7 UCB

11.7.1 UCB Company Details

11.7.2 UCB Business Overview

11.7.3 UCB Parkinson’s Disease Treatment Introduction

11.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.7.5 UCB Recent Developments

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Parkinson’s Disease Treatment Introduction

11.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.8.5 AbbVie Recent Developments

11.9 MSD

11.9.1 MSD Company Details

11.9.2 MSD Business Overview

11.9.3 MSD Parkinson’s Disease Treatment Introduction

11.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.9.5 MSD Recent Developments

11.10 Orion Pharmaceuticals

11.10.1 Orion Pharmaceuticals Company Details

11.10.2 Orion Pharmaceuticals Business Overview

11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Introduction

11.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.10.5 Orion Pharmaceuticals Recent Developments

11.11 Intec Pharma

11.11.1 Intec Pharma Company Details

11.11.2 Intec Pharma Business Overview

11.11.3 Intec Pharma Parkinson’s Disease Treatment Introduction

11.11.4 Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.11.5 Intec Pharma Recent Developments

11.12 NeuroDerm

11.12.1 NeuroDerm Company Details

11.12.2 NeuroDerm Business Overview

11.12.3 NeuroDerm Parkinson’s Disease Treatment Introduction

11.12.4 NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.12.5 NeuroDerm Recent Developments

11.13 Adamas Therapeutics

11.13.1 Adamas Therapeutics Company Details

11.13.2 Adamas Therapeutics Business Overview

11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Introduction

11.13.4 Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.13.5 Adamas Therapeutics Recent Developments

11.14 Acadia

11.14.1 Acadia Company Details

11.14.2 Acadia Business Overview

11.14.3 Acadia Parkinson’s Disease Treatment Introduction

11.14.4 Acadia Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.14.5 Acadia Recent Developments

11.15 Sunovion

11.15.1 Sunovion Company Details

11.15.2 Sunovion Business Overview

11.15.3 Sunovion Parkinson’s Disease Treatment Introduction

11.15.4 Sunovion Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.15.5 Sunovion Recent Developments

11.16 GSK

11.16.1 GSK Company Details

11.16.2 GSK Business Overview

11.16.3 GSK Parkinson’s Disease Treatment Introduction

11.16.4 GSK Revenue in Parkinson’s Disease Treatment Business (2019-2024)

11.16.5 GSK Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Impax Pharmaceuticals

UCB

AbbVie

MSD

Orion Pharmaceuticals

List of Tables

Table 1. Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Oral

Table 3. Key Players of Transdermal

Table 4. Key Players of Subcutaneous

Table 5. Key Players of Intestinal Infusion

Table 6. Global Parkinson’s Disease Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Parkinson’s Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Parkinson’s Disease Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Parkinson’s Disease Treatment Market Share by Region (2019-2024)

Table 10. Global Parkinson’s Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Parkinson’s Disease Treatment Market Share by Region (2025-2030)

Table 12. Parkinson’s Disease Treatment Market Trends

Table 13. Parkinson’s Disease Treatment Market Drivers

Table 14. Parkinson’s Disease Treatment Market Challenges

Table 15. Parkinson’s Disease Treatment Market Restraints

Table 16. Global Parkinson’s Disease Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Parkinson’s Disease Treatment Revenue Share by Players (2019-2024)

Table 18. Global Top Parkinson’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Treatment as of 2023)

Table 19. Global Parkinson’s Disease Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Parkinson’s Disease Treatment, Headquarters and Area Served

Table 22. Global Key Players of Parkinson’s Disease Treatment, Product and Application

Table 23. Global Key Players of Parkinson’s Disease Treatment, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Parkinson’s Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Parkinson’s Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Parkinson’s Disease Treatment Revenue Share by Application (2019-2024)

Table 31. Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Parkinson’s Disease Treatment Revenue Share by Application (2025-2030)

Table 33. North America Parkinson’s Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Parkinson’s Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Parkinson’s Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Parkinson’s Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Parkinson’s Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Parkinson’s Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Parkinson’s Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Parkinson’s Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Parkinson’s Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Parkinson’s Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Parkinson’s Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Parkinson’s Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Parkinson’s Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Parkinson’s Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Parkinson’s Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Parkinson’s Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Parkinson’s Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Parkinson’s Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Parkinson’s Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Parkinson’s Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Parkinson’s Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Parkinson’s Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Parkinson’s Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Parkinson’s Disease Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Parkinson’s Disease Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 65. Teva Company Details

Table 66. Teva Business Overview

Table 67. Teva Parkinson’s Disease Treatment Product

Table 68. Teva Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 69. Teva Recent Developments

Table 70. Roche Company Details

Table 71. Roche Business Overview

Table 72. Roche Parkinson’s Disease Treatment Product

Table 73. Roche Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 74. Roche Recent Developments

Table 75. Prothena Company Details

Table 76. Prothena Business Overview

Table 77. Prothena Parkinson’s Disease Treatment Product

Table 78. Prothena Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 79. Prothena Recent Developments

Table 80. Acorda Therapeutics Company Details

Table 81. Acorda Therapeutics Business Overview

Table 82. Acorda Therapeutics Parkinson’s Disease Treatment Product

Table 83. Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 84. Acorda Therapeutics Recent Developments

Table 85. Voyager Therapeutics Company Details

Table 86. Voyager Therapeutics Business Overview

Table 87. Voyager Therapeutics Parkinson’s Disease Treatment Product

Table 88. Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 89. Voyager Therapeutics Recent Developments

Table 90. Impax Pharmaceuticals Company Details

Table 91. Impax Pharmaceuticals Business Overview

Table 92. Impax Pharmaceuticals Parkinson’s Disease Treatment Product

Table 93. Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 94. Impax Pharmaceuticals Recent Developments

Table 95. UCB Company Details

Table 96. UCB Business Overview

Table 97. UCB Parkinson’s Disease Treatment Product

Table 98. UCB Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 99. UCB Recent Developments

Table 100. AbbVie Company Details

Table 101. AbbVie Business Overview

Table 102. AbbVie Parkinson’s Disease Treatment Product

Table 103. AbbVie Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 104. AbbVie Recent Developments

Table 105. MSD Company Details

Table 106. MSD Business Overview

Table 107. MSD Parkinson’s Disease Treatment Product

Table 108. MSD Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 109. MSD Recent Developments

Table 110. Orion Pharmaceuticals Company Details

Table 111. Orion Pharmaceuticals Business Overview

Table 112. Orion Pharmaceuticals Parkinson’s Disease Treatment Product

Table 113. Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 114. Orion Pharmaceuticals Recent Developments

Table 115. Intec Pharma Company Details

Table 116. Intec Pharma Business Overview

Table 117. Intec Pharma Parkinson’s Disease Treatment Product

Table 118. Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 119. Intec Pharma Recent Developments

Table 120. NeuroDerm Company Details

Table 121. NeuroDerm Business Overview

Table 122. NeuroDerm Parkinson’s Disease Treatment Product

Table 123. NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 124. NeuroDerm Recent Developments

Table 125. Adamas Therapeutics Company Details

Table 126. Adamas Therapeutics Business Overview

Table 127. Adamas Therapeutics Parkinson’s Disease Treatment Product

Table 128. Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 129. Adamas Therapeutics Recent Developments

Table 130. Acadia Company Details

Table 131. Acadia Business Overview

Table 132. Acadia Parkinson’s Disease Treatment Product

Table 133. Acadia Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 134. Acadia Recent Developments

Table 135. Sunovion Company Details

Table 136. Sunovion Business Overview

Table 137. Sunovion Parkinson’s Disease Treatment Product

Table 138. Sunovion Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 139. Sunovion Recent Developments

Table 140. GSK Company Details

Table 141. GSK Business Overview

Table 142. GSK Parkinson’s Disease Treatment Product

Table 143. GSK Revenue in Parkinson’s Disease Treatment Business (2019-2024) & (US$ Million)

Table 144. GSK Recent Developments

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Parkinson’s Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Parkinson’s Disease Treatment Market Share by Type: 2023 VS 2030

Figure 3. Oral Features

Figure 4. Transdermal Features

Figure 5. Subcutaneous Features

Figure 6. Intestinal Infusion Features

Figure 7. Global Parkinson’s Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Parkinson’s Disease Treatment Market Share by Application: 2023 VS 2030

Figure 9. Hospital Pharmacy Case Studies

Figure 10. Retail Pharmacy Case Studies

Figure 11. Online Pharmacy Case Studies

Figure 12. Parkinson’s Disease Treatment Report Years Considered

Figure 13. Global Parkinson’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Parkinson’s Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Parkinson’s Disease Treatment Market Share by Region: 2023 VS 2030

Figure 16. Global Parkinson’s Disease Treatment Market Share by Players in 2023

Figure 17. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Treatment as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Parkinson’s Disease Treatment Revenue in 2023

Figure 19. North America Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Parkinson’s Disease Treatment Market Share by Type (2019-2030)

Figure 21. North America Parkinson’s Disease Treatment Market Share by Application (2019-2030)

Figure 22. North America Parkinson’s Disease Treatment Market Share by Country (2019-2030)

Figure 23. United States Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Parkinson’s Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Parkinson’s Disease Treatment Market Share by Type (2019-2030)

Figure 27. Europe Parkinson’s Disease Treatment Market Share by Application (2019-2030)

Figure 28. Europe Parkinson’s Disease Treatment Market Share by Country (2019-2030)

Figure 29. Germany Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Parkinson’s Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Parkinson’s Disease Treatment Market Share by Type (2019-2030)

Figure 37. China Parkinson’s Disease Treatment Market Share by Application (2019-2030)

Figure 38. Asia Parkinson’s Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Parkinson’s Disease Treatment Market Share by Type (2019-2030)

Figure 40. Asia Parkinson’s Disease Treatment Market Share by Application (2019-2030)

Figure 41. Asia Parkinson’s Disease Treatment Market Share by Region (2019-2030)

Figure 42. Japan Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Parkinson’s Disease Treatment Market Share by Country (2019-2030)

Figure 52. Brazil Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Parkinson’s Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Teva Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 59. Roche Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 60. Prothena Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 61. Acorda Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 62. Voyager Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 63. Impax Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 64. UCB Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 65. AbbVie Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 66. MSD Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 67. Orion Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 68. Intec Pharma Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 69. NeuroDerm Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 70. Adamas Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 71. Acadia Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 72. Sunovion Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 73. GSK Revenue Growth Rate in Parkinson’s Disease Treatment Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030

Global Anti Parkinson Drugs Market Insights Forecast to 2030

Global Neurodegenerative Disease Market Insights Forecast to 2030

Global Parkinson Disease Drug Market Insights Forecast to 2030

Global Anti Parkinson s Disease Drugs Market Research Report 2024

Global Alzheimer s Disease Drug Market Insights Forecast to 2030

Global Alzheimer s Disease Treatments Market Research Report 2024

Global Parkinsons Disease Drug Market Insights Forecast to 2030

Global Parkinson s Disease PD Drugs Market Research Report 2024

Global Alzheimer Treatment Drug Market Research Report 2025

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Neurodegenerative Disease Treatment Market Research Report 2024

Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030

Global Targeted Drugs for Parkinson s Disease Market Research Report 2024

Global Peyronie s Disease Treatment Market Insights Forecast to 2030

Global Gaucher Disease GD Drugs Market Insights Forecast to 2030

Global Parkinson Treatment Drug Market Research Report 2025

Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions